Rare diseases
Investigational molecules
Locations
Back to Estonia144 clinical trials in Tartu, Estonia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy
EstoniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
EstoniaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
EstoniaStudy on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
EstoniaStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
EstoniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
EstoniaStudy on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
EstoniaStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
EstoniaEfficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
EstoniaEstoniaA Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes
EstoniaStudy on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination
EstoniaThe busiest research cities in the country
What the registry says about research in the country
Several trials focusing on innovative treatments for autoimmune disorders, particularly investigating new therapies for psoriatic arthritis and plaque psoriasis. Research includes testing of novel compounds like zasocitinib and evaluating long-term safety profiles.
Studies aim to improve disease management and patient outcomes through targeted therapies.
Comprehensive cancer research programs examining treatments for various types of lung cancer and other malignancies. Studies focus on combination therapies and novel treatment approaches.
Emphasis on immunotherapy combinations and targeted treatments for better patient outcomes.
Investigation of treatments for osteoporosis and related conditions, with a focus on postmenopausal women and innovative therapeutic approaches.
Research aims to improve bone health and manage metabolic conditions through new therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
